{"id":71614,"date":"2023-10-26T12:53:16","date_gmt":"2023-10-26T12:53:16","guid":{"rendered":"https:\/\/insights.greyb.com\/?post_type=ht_kb&p=71614"},"modified":"2025-03-25T11:21:11","modified_gmt":"2025-03-25T11:21:11","slug":"coimmune-patents","status":"publish","type":"ht_kb","link":"https:\/\/insights.greyb.com\/coimmune-patents\/","title":{"rendered":"CoImmune Patents \u2013 Insights & Stats (Updated 2023)"},"content":{"rendered":"\n

CoImmune has a total of 142 patents globally, out of which 92 have been granted. Of these 142 patents, more than 76% patents are active. The United States of America is where CoImmune has filed the maximum number of patents, followed by Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of CoImmune.<\/p>\n\n\n\n

CoImmune was founded in 2019. CoImmune is a clinical-stage immuno-oncology company that is privately held and aims to revolutionize cancer therapy using cellular immunotherapies. The company’s innovative CAR therapy, the allogeneic CAR-CIK technology platform for liquid and solid malignancies, promises improved efficacy with significantly less toxicity.<\/p>\n\n\n\n

Do read about some of the most popular patents of CoImmune which have been covered by us in this article and also you can find CoImmune patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over CoImmune patent portfolio.<\/p>\n\n\n\n

How many patents does <\/strong>CoImmune <\/strong>have?<\/strong><\/h3>\n\n\n\n

CoImmune has a total of 142 patents globally. These patents belong to 31 unique patent families. Out of 142 patents, 109 patents are active.<\/p>\n\n\n\n

How Many Patents did CoImmune File Every Year?<\/strong><\/h3>\n\n\n\n
\"CoImmune<\/a><\/figure>\n\n\n\n

Are you wondering why there is a drop in patent filing for the last two years? <\/strong>It is because a patent application can take up to 18 months to get published. Certainly, it doesn\u2019t suggest a decrease in the patent filing.<\/p>\n\n\n\n

Year of Patents Filing or Grant<\/strong><\/td>CoImmune Applications Filed<\/strong><\/td>CoImmune Patents Granted<\/strong><\/td><\/tr>
2023<\/td>–<\/td>1<\/td><\/tr>
2022<\/td>3<\/td>3<\/td><\/tr>
2021<\/td>9<\/td>4<\/td><\/tr>
2020<\/td>5<\/td>4<\/td><\/tr>
2019<\/td>3<\/td>4<\/td><\/tr>
2018<\/td>5<\/td>6<\/td><\/tr>
2017<\/td>3<\/td>7<\/td><\/tr>
2016<\/td>6<\/td>8<\/td><\/tr>
2015<\/td>11<\/td>4<\/td><\/tr>
2014<\/td>3<\/td>12<\/td><\/tr>
2013<\/td>6<\/td>14<\/td><\/tr>
2012<\/td>7<\/td>11<\/td><\/tr>
2011<\/td>3<\/td>6<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

How many <\/strong>CoImmune <\/strong>patents are Alive\/Dead?<\/strong><\/h3>\n\n\n\n

Worldwide Patents<\/strong><\/p>\n\n\n\n

\"CoImmune<\/a><\/figure>\n\n\n\n

How Many Patents did CoImmune File in Different Countries?<\/strong><\/h3>\n\n\n\n
\"CoImmune<\/a><\/figure>\n\n\n\n

Countries in which CoImmune Filed Patents<\/strong><\/p>\n\n\n\n

Country<\/strong><\/td>Patent<\/strong><\/td><\/tr>
United States Of America<\/td>56<\/td><\/tr>
Australia<\/td>20<\/td><\/tr>
Korea (South)<\/td>13<\/td><\/tr>
Canada<\/td>13<\/td><\/tr>
Europe<\/td>9<\/td><\/tr>
China<\/td>8<\/td><\/tr>
Israel<\/td>6<\/td><\/tr>
Hong Kong (S.A.R.)<\/td>5<\/td><\/tr>
Germany<\/td>3<\/td><\/tr>
Spain<\/td>2<\/td><\/tr>
Austria<\/td>1<\/td><\/tr>
Japan<\/td>1<\/td><\/tr>
South Africa<\/td>1<\/td><\/tr>
Italy<\/td>1<\/td><\/tr>
Norway<\/td>1<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Where are Research Centers of CoImmune Patents\u00a0Located?<\/strong><\/h3>\n\n\n\n
\"R&D<\/a><\/figure>\n\n\n\n

10 Best <\/strong>CoImmune <\/strong>Patents<\/strong><\/strong><\/h3>\n\n\n\n

US8030080B2<\/a> is the most popular patent in the CoImmune portfolio. It has received 64 citations so far from companies like Rheonix, Theranos, Abbott.<\/p>\n\n\n\n

Below is the list of 10 most cited patents of CoImmune:<\/strong><\/p>\n\n\n\n

Publication Number<\/strong><\/td>Citation Count<\/strong><\/td><\/tr>
US8030080B2<\/a><\/td>64<\/td><\/tr>
US7169898B2<\/a><\/td>30<\/td><\/tr>
US8672879B2<\/a><\/td>26<\/td><\/tr>
US8211701B2<\/a><\/td>18<\/td><\/tr>
US7198948B2<\/a><\/td>14<\/td><\/tr>
US20120269832A1<\/a><\/td>12<\/td><\/tr>
US8431404B2<\/a><\/td>11<\/td><\/tr>
US7785583B2<\/a><\/td>11<\/td><\/tr>
US8236562B2<\/a><\/td>7<\/td><\/tr>
US20130280805A1<\/a><\/td>6<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

What are CoImmune<\/strong> key innovation segments?<\/strong><\/h3>\n\n\n\n\n